Spring 2007
J e f f e r s o n C a n c e r N e t w o r k recently received a certificate of recognition from the JCN for her News efforts in clinical trial enrollments in 2006.
The complete list of recognition awards for 2006 is as follows: For highest overall institutional accrual; Albert Einstein Cancer Message from the Clinical
Center, Hematology & Oncology Associates of NEPA, Alfred I.
Director, Walter J. Curran Jr., MD
duPont Hospital for Children, Frankford Hospitals and Pocono I am pleased to present the Spring 2007 issue of the Jefferson Cancer Network News. As our cancer network begins its 15th Recognition awards for the highest number of patients enrolled year in operation, it is clear that we have much work yet to by investigator went to Dr. William Tester of the Albert Einstein do to increase awareness and clinical trial participation. Our Cancer Center, Dr. William Heim of Hematology & Oncology coordinators are working with the member investigators and Associates of NEPA, Dr. Michael Greenberg of Pocono Medical research coordinators to ensure that they have access to trials Center, Dr. Cheryl Gardner of Ephrata Cancer Center, and Drs.
that fit the needs of their patient population. Please let us Jonathon Powell and Gregory Griffin both of duPont Hospital know what else we can do to ensure that clinical trials are Jefferson Cancer Network
available to all patients in our network. Feel free to email me or Patricia Dugan at [email protected] Recognition for timely data submission was awarded to Sally Albert Einstein Medical Center
and [email protected], respectively with Wagenborg of Frankford Hospitals, Dan Ward of Ephrata Cancer Alfred I. duPont Hospital for Children
Center and Betsy Mead & LeeAnn Haefele both of Hematology Brandywine Hospital
I hope you will enjoy “meeting” our featured investigators in this Ephrata Community Hospital
issue. I am happy to report that Dr. Cheryl Gardner of Ephrata Congratulations to all for your hard work and success in 2006! Frankford Hospitals
Hematology & Oncology Associates of
Northeastern PA PC
Featured Clinical Trials: NSABP B-42, TAILORx and NSABP FRP FB-4
Hudson Valley Oncology Associates
NSABP B-42 is a phase III ran-
Jefferson Hospital for Neuroscience
Kimmel Cancer Center at Jefferson double-blind study to deter-
Jefferson Radiation Oncology Center
at Chestnut Hill hormonal therapy with letro-
TAILORx stands for “Trial
Jefferson Radiation Oncology Center
at Lower Bucks
Memorial Hospital of Salem County
NSABP FRP FB-4 is a phase II
Mercy Fitzgerald Hospital
Mercy Hospital of Philadelphia
Mercy Suburban Hospital
April 27 – 30, 2007
June 8 – 10, 2007
June 20, 2007
Methodist Hospital
Montgomery Hospital Medical Center
Northeast Radiation Oncology Center
May 2 – 3, 2007
June 16, 2007
June 21 – 24, 2007
Pocono Medical Center
Riddle Memorial Hospital
Sacred Heart Hospital
Sparta Cancer Treatment Center
Please note that the JCN has recently moved to a new Underwood-Memorial Hospital
Contact the editor,
location on campus. We are now located at 1015 Chestnut Colleen M. Cohick, MPH, at
Street, Suite 622. Telephone numbers are the same, but Upper Delaware Valley Cancer Center
[email protected]
we have a new fax number, 215-955-1020.
Wills Eye at Jefferson
Working Together in Cancer Care,
Education and Research
Jefferson Cancer Network News Spring 2007 www.kimmelcancercenter.org
HDQ Update
JOG 031 An Open-Label,
Learning to Live
Genetic Counselor, Sarah
Better with the
Charles, MS, is a recent
Stress of Cancer
JOG 036 A Randomized
Recorded Decline
JOG 037 A Randomized,
in Cancer Deaths
JOG 032 A Randomized Study
[email protected]
with Metastatic or RecurrentH&N Cancer Congratulations to Fran Guiles,
RHIA, CTR, Manager of
JOG 038 Induction Therapy
Call For Volunteers
JOG 033 A Multicenter, Open-
Label, Single-Arm, 2-Stage
35th Annual
Putting Patients First
Elizabeth “Michelle” Quinones
medical research,” said Richard
Pestell, MD, PhD, director of the
JOG 034 A Randomized,
Research Nurse, Lorie Matson,
BSN, at 610-627-4480. All you
JOG 035 A Randomized,
Open JOG Trials
JOG 030 A Phase 2 Trial of
: Ephrata Cancer Center
Wilfred Layne, MD serves as the principal investi-
Korea. She completed her fellowship at the gator and Medical Director at Ephrata Cancer University of Maryland, and has been practicing Center. He is a medical oncologist and has been at Ephrata since 2002. Dr. Layne received hisMD from St. George’s University of School of All the physicians are board certified in internal Medicine. He completed his fellowship at SUNY.
medicine, hematology, and medical oncology.
Dan Ward, RN is the clinical research nurse at the
Cheryl Gardner, DO joined Ephrata in 2001. She
earned her Doctorate of Osteopathic Medicine
cancer center. He is a graduate of Reading Area from the Philadelphia College of Osteopathic Community College and has enjoyed working at Medicine. Dr. Gardner completed her internship and residency at Delaware Valley MedicalCenter, and her fellowship at SUNY.
So Hyang Park, MD is a graduate of Kyung Pook
National University, School of Medicine, Taegu,
Cheryl Gardner, DO; Wilfred Layne, MD; So Hyang Park, MD; Dan Ward, RN

Source: http://www.kcc.tju.edu/jkccn/documents/2007-spring-newsletter.pdf

Microsoft word - @3h208!.doc

Comparison of VA National Formulary and Formularies of the Highest Enrollment Plans in Medicare Part D and the Federal Employee Health Benefit Program Prepared for: PhRMA The Lewin Group, Inc. December 10, 2008 Comparison of VA National Formulary and Formularies of the Highest Enrollment Plans in Medicare Part D and the Federal Employee Health Benefi


Medizinisches Onlinemagazin Personalisiert und einzigartig auf der Welt. Jetzt ganz neu im Internet, auch auf ihrem Browser zu sehen! Gehen Sie einfach nur auf Das weltweit erste personalisierte Online-Magazin DAS WELTWEIT ERSTE PERSONALISIERTE ONLINE-MAGAZINMit Diabetes im Kindergarten - ein Problem?Im Kindergarten können die Jüngsten nach Herzens-gepackt werden. Um Probleme so w

Copyright © 2009-2018 Drugs Today